These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13502020)

  • 1. The use of plasmin in the treatment of intravascular thromboses.
    CLIFFTON EE
    J Am Geriatr Soc; 1958 Feb; 6(2):118-27. PubMed ID: 13502020
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of thrombosis with fibrinolysin (plasmin).
    SOKAL JE; AMBRUS JL; AMBRUS CM
    J Am Med Assoc; 1958 Nov; 168(10):1314-23. PubMed ID: 13587211
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasmin & therapy of thrombosis].
    JURGENS J
    Dtsch Med Wochenschr; 1958 Dec; 83(52):2342-3. PubMed ID: 13619379
    [No Abstract]   [Full Text] [Related]  

  • 4. FIBRINOLYSIN for treatment of blood-clots in man.
    Lancet; 1958 Sep; 2(7047):624-5. PubMed ID: 13588952
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic reaction after intravenous fibrinolysin therapy.
    BOYLES PW
    J Am Med Assoc; 1959 Jun; 170(9):1045-7. PubMed ID: 13664485
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of heparin, plasmin, dextran, and low molecular dextran on bioelectrically induced thromboses.
    Flemma RJ; Silver D; Anlyan WG
    Surg Forum; 1965; 16():123-4. PubMed ID: 4220793
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of intravenous human fibrinolysin as a treatment for recent intravascular thrombosis.
    WATT DL; MACMILLAN RL
    Can Med Assoc J; 1960 Dec; 83(27):1436-7. PubMed ID: 13783453
    [No Abstract]   [Full Text] [Related]  

  • 8. [The application of fibrinolysin in thromboses and its effect on some indices of the blood coagulation system (preliminary report)].
    Ripiakh VL
    Probl Gematol Pereliv Krovi; 1966 Apr; 11(4):56-60. PubMed ID: 4229564
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombosis prophylaxis using plasmin and its combination with alpha-adrenoreceptor antagonists].
    Grigoréva ME; Kalishevskaia TM; Golubeva MG
    Fiziol Zh (1978); 1992; 38(6):42-9. PubMed ID: 1364112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrinolysin-anticoagulant therapy of cerebral thromboses].
    Lunev DK; Shmyrev VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(8):1121-8. PubMed ID: 4263309
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of fibrinolysin in vascular thromboses. (Apropos of 16 cases)].
    COURBIER R; TORRESANI J; MONTIES JR
    Mars Chir; 1960; 12():390-5. PubMed ID: 13695962
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary arterial and other intravascular thromboses treated with fibrinolysin. Experimental and clinical results.
    MAZEL MS; BOLTON HE; STERN JR; RIERA R; CABRAL H
    Angiology; 1963 Feb; 14():88-92. PubMed ID: 13934202
    [No Abstract]   [Full Text] [Related]  

  • 13. Revival of plasmin as a therapeutic agent?
    Collen D
    Thromb Haemost; 2001 Sep; 86(3):731-2. PubMed ID: 11583301
    [No Abstract]   [Full Text] [Related]  

  • 14. The treatment of acute abscesses with human plasmin (fibrinolysin).
    BIRD F; CLIFFTON EE
    Surgery; 1957 Jul; 42(1):249-55. PubMed ID: 13442896
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
    Marder VJ
    Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of fibrinolysin (plasmin) in thromboembolic diseases].
    MACIAS CASTRO I
    Arch Hosp Univ; 1958; 10(6):463-6. PubMed ID: 13628412
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombolysis with fibrinolysin (plasmin)-new therapeutic approach to thromboembolism.
    MOSER KM
    J Am Med Assoc; 1958 Aug; 167(14):1695-704. PubMed ID: 13563166
    [No Abstract]   [Full Text] [Related]  

  • 18. Central retinal artery occlusion successfully treated with plasmin.
    HECKER SP; ZWENG HC
    JAMA; 1961 Jul; 176():1067-9. PubMed ID: 13712671
    [No Abstract]   [Full Text] [Related]  

  • 19. [The exogenous plasmin phase in fibrinolytic therapy].
    Fischbacher W
    Schweiz Med Wochenschr; 1968 Oct; 98(42):1645-8. PubMed ID: 4235241
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of a combination of fibrinolysin, heparin and a fibrinolysin-heparin complex with dihydroergotoxine on thrombolysis].
    Kalishevskaia TM; Golubeva MG; Bashkov GV; Vinter VB
    Fiziol Zh (1978); 1988; 34(3):88-93. PubMed ID: 2842201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.